Category Archive
Filter Telehealth updates.
Filter updates by state, jurisdiction, clinic type, service line, command zone, and impact level.
EffectiveHigh Impact
DEA and HHS extend controlled-substance telehealth flexibilities through 2026
DEA and HHS extended telemedicine flexibilities allowing controlled-medication prescribing without a prior in-person visit, when conditions are met, through December 31, 2026.
Operator impact: TRT, ketamine, psychiatry, and other controlled-substance cash-pay models should treat 2026 as a compliance-hardening window before permanent rules are finalized.
Effective Jan 1, 2026
Deadline Dec 31, 2026
EffectiveHigh Impact
Florida requires out-of-state telehealth providers to register
Florida requires out-of-state health care practitioners to register with the Florida Department of Health before providing telehealth services to Florida patients.
Operator impact: Telehealth weight-loss, hormone, mental health, DPC, and longevity clinics serving Florida patients should verify provider registration, scope limits, malpractice coverage, medical records, and prescribing boundaries.
EffectiveHigh Impact
New Jersey requires telemedicine and telehealth organizations to register
New Jersey requires telehealth and telemedicine companies providing or intending to provide services in the state to register with the Department of Health.
Operator impact: Telehealth clinics serving New Jersey should verify organization registration, provider licensure, patient records, prescribing rules, vendor contracts, and whether service-line launches trigger registry updates.
EffectiveHigh Impact
North Carolina telemedicine position statement reinforces prescribing accountability
North Carolina Medical Board telemedicine position statement states that telemedicine prescribing carries the same professional accountability as in-person prescribing and must comply with state and federal law.
Operator impact: North Carolina telehealth clinics should review documentation, patient identity, medical records, informed consent, controlled-substance reporting, prescribing appropriateness, and escalation workflows.
ProposedMedium Impact
New York telehealth and patient communication watch opened
New York is queued for ongoing review around hybrid care, telehealth intake, asynchronous follow-up, and SMS/email patient communication workflows.
Operator impact: Clinics should confirm provider licensing, informed consent, patient recordkeeping, and automated message safeguards.
EffectiveHigh Impact
New Jersey Schedule II telehealth prescribing creates in-person exam risk point
New Jersey telehealth prescribing rules for Schedule II controlled substances create in-person exam and follow-up requirements that may apply even where federal telehealth flexibility remains available.
Operator impact: New Jersey psychiatry, ADHD, pain, and controlled-substance telehealth models should review in-person exam workflows, every-three-month visit rules, recordkeeping, PDMP checks, and provider licensing.
